[go: up one dir, main page]

BE758942A - MEDICINAL PRODUCT FOR THE TREATMENT OF INFECTIOUS AND / OR INFLAMMATORY CONDITIONS - Google Patents

MEDICINAL PRODUCT FOR THE TREATMENT OF INFECTIOUS AND / OR INFLAMMATORY CONDITIONS

Info

Publication number
BE758942A
BE758942A BE758942DA BE758942A BE 758942 A BE758942 A BE 758942A BE 758942D A BE758942D A BE 758942DA BE 758942 A BE758942 A BE 758942A
Authority
BE
Belgium
Prior art keywords
infectious
treatment
inflammatory conditions
medicinal product
medicinal
Prior art date
Application number
Other languages
French (fr)
Original Assignee
Abbou Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE758942A publication Critical patent/BE758942A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE758942D 1969-11-15 MEDICINAL PRODUCT FOR THE TREATMENT OF INFECTIOUS AND / OR INFLAMMATORY CONDITIONS BE758942A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6939348A FR2068431A1 (en) 1969-11-15 1969-11-15

Publications (1)

Publication Number Publication Date
BE758942A true BE758942A (en) 1971-04-16

Family

ID=9043124

Family Applications (1)

Application Number Title Priority Date Filing Date
BE758942D BE758942A (en) 1969-11-15 MEDICINAL PRODUCT FOR THE TREATMENT OF INFECTIOUS AND / OR INFLAMMATORY CONDITIONS

Country Status (5)

Country Link
BE (1) BE758942A (en)
DE (1) DE2055667A1 (en)
FR (1) FR2068431A1 (en)
GB (1) GB1332812A (en)
NL (1) NL7016783A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829136B1 (en) * 2001-08-29 2006-11-17 Aventis Pharma Sa LIPID DERIVATIVES OF AMINOGLYCOSIDES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB819793A (en) * 1956-04-19 1959-09-09 Upjohn Co Therapeutic compositions containing steroid and antibiotic

Also Published As

Publication number Publication date
NL7016783A (en) 1971-05-18
DE2055667A1 (en) 1971-05-27
FR2068431A1 (en) 1971-08-27
GB1332812A (en) 1973-10-03

Similar Documents

Publication Publication Date Title
BE773910A (en) COMPOSITION FOR THE TREATMENT OF HEPATIC DISORDERS AND INTELLECTUAL OVEREXAMPLE
BE778149A (en) NEW PRODUCTS FOR THE TREATMENT AND HYGIENE OF THE SKIN
BE761444A (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MICROBIAL INFECTIONS
FR2341315A1 (en) MEDICINES FOR THE TREATMENT OF NEUROPATHIES
BE829859A (en) PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE773121A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HYPERLIPIDEMIA AND THEIR PROCESS FOR OBTAINING THEIR
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
BE758942A (en) MEDICINAL PRODUCT FOR THE TREATMENT OF INFECTIOUS AND / OR INFLAMMATORY CONDITIONS
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1508496A (en) Product and method for the assay of amylase
BE757590A (en) PRODUCTS FOR THE TREATMENT AND HYGIENE OF ORAL CAVITY
BE791253A (en) NEW PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HYPERTONIA
BE824022A (en) PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF LEUKOSIS AND NEVROSIC SYNDROMES
FR2310768A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA SENILIS
BE829024A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYDROPISIS
BE751577A (en) MEDICINE FOR THE TREATMENT OF MIGRAINE
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
BE854265A (en) MEDICINAL PRODUCT FOR THE TREATMENT OF PRIMARY AND SECONDARY HYPERLIPOROTEINEMIA
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
BE778928A (en) MEDICINAL PRODUCT THAT CAN BE USED IN PARTICULAR FOR THE TREATMENT OF CERTAIN VASCULAR DISORDERS
BE768809A (en) NEW MEDICINES USEFUL IN PARTICULAR FOR THE TREATMENT OF HEART DISORDERS